4 free views remaining today
hereditary alpha tryptasemia syndrome
ICD-10 Codes
Related ICD-10:
Description
Hereditary Alpha Tryptasemia Syndrome (HATS) is a genetic condition characterized by elevated levels of alpha-tryptase in the blood, which can lead to a wide range of symptoms affecting multiple organ systems.
Causes and Prevalence HATS is caused by an increased copy number of the TPSAB1 gene encoding alpha-tryptase, leading to high tryptase levels at baseline. This condition occurs in approximately 5.5% of the general population where it has been studied, with the majority of affected individuals being white.
Symptoms The symptoms of HATS can vary from mild to severe and may include:
- Allergic-like symptoms: skin itching, flushing, hives, or anaphylaxis
- Gastrointestinal symptoms: bloating, abdominal pain, diarrhea, and/or constipation (often diagnosed as irritable bowel syndrome)
- Neuropsychiatric symptoms: exhaustion, depressive episodes, sleep disturbances, and memory issues
Other Key Points
- HATS is a genetic trait that can be inherited from one's parents.
- The condition is often asymptomatic in most individuals, but some may experience a range of symptoms.
- Elevated tryptase levels are the hallmark of this condition.
References:
[3] Hereditary alpha-tryptasemia (HaT) is a common autosomal dominant genetic trait, first identified in 2016, which is defined by increased TPSAB1 gene copy number encoding alpha (a)-tryptase and characterized by elevated serum levels of total tryptase at baseline.
[13] Hereditary Alpha Tryptasemia (HαT) manifests a wide array of symptoms, which can range from mild to severe, and in some instances, individuals might not exhibit any noticeable symptoms. The variability and non-specific nature of these symptoms often make HαT a challenging condition to identify.
[15] Hereditary alpha tryptasemia syndrome is a condition characterized by high blood tryptase levels, and by several symptoms associated with multiple organ systems. These symptoms may include allergic-like symptoms (skin itching, flushing, hives, or anaphylaxis); gastrointestinal symptoms such as bloating, abdominal pain, diarrhea and/or constipation (often diagnosed as irritable bowel syndrome...
Additional Characteristics
- Allergic-like symptoms: skin itching, flushing, hives, or anaphylaxis
- or constipation (often diagnosed as irritable bowel syndrome)
- Neuropsychiatric symptoms: exhaustion, depressive episodes, sleep disturbances, and memory issues
Signs and Symptoms
Hereditary Alpha Tryptasemia (HAT) syndrome is a genetic disorder characterized by elevated levels of alpha tryptase in the blood, leading to various symptoms. Here are some of the common signs and symptoms associated with HAT:
- Skin-related symptoms: Flushing, rashes, itching, and hives are commonly reported in individuals with HAT [3][5].
- Digestive issues: Abdominal complaints similar to Irritable Bowel Syndrome (IBS) have been observed in some cases [1][7].
- Cardiovascular symptoms: Elevated tryptase levels can lead to heart-related issues, although the exact mechanisms are not well understood [2].
- Musculoskeletal symptoms: Muscle and bone pain, as well as joint complaints, have been reported in individuals with HAT [2].
- Mental health concerns: Some people with HAT may experience anxiety, depression, or other mental health-related issues [2].
- Chronic pain: Persistent pain is a common symptom in individuals with HAT, affecting various parts of the body [2].
It's essential to note that not everyone with HAT will experience all of these symptoms, and their severity can vary from person to person. If you suspect you or someone else may have HAT, consult a healthcare professional for proper diagnosis and treatment.
References: [1] Context result 1 [2] Context result 4 [3] Context result 3 [5] Context result 5 [7] Context result 7
Additional Symptoms
- hives
- rashes
- abdominal complaints (similar to IBS)
- heart-related issues
- muscle and bone pain
- joint complaints
- other mental health concerns
- flushing
- itching
- anxiety
- depression
- chronic pain
Diagnostic Tests
Hereditary Alpha Tryptasemia (HαT) is a genetic disorder characterized by an excess of alpha tryptase, a protein involved in allergic reactions and immune responses. Diagnosing HαT requires a combination of clinical evaluation and laboratory tests.
Initial Evaluation
The first step in diagnosing HαT involves measuring the total serum tryptase level. In most individuals with HαT, serum tryptase levels are elevated [3]. This test is usually performed by a physician as part of an initial evaluation for suspected allergic or immune disorders.
Genetic Testing
A more specific diagnosis of HαT can be made through genetic testing, which involves assessing the copy number variation (CNV) of the TPSAB1 gene. This gene encodes for alpha tryptase, and individuals with HαT typically have extra copies of this gene [4]. Gene-by-Gene is a laboratory that offers a Tryptase Copy Number Variation Test to diagnose HαT [1].
Other Diagnostic Tests
While not specifically designed to diagnose HαT, tryptase testing can be useful in evaluating patients with suspected allergic or immune disorders. Additionally, droplet digital PCR (ddPCR) can be used to assess for the presence of TPSAB1 CNVs and aid in the diagnosis of HαT [9].
References
- Gene-by-Gene provides a Tryptase Copy Number Variation Test online [2].
- Elevated serum tryptase levels are characteristic of HαT [3].
- Genetic testing can confirm the diagnosis of HαT by assessing TPSAB1 CNVs [4].
- ddPCR can be used to aid in the diagnosis of HαT [9].
Additional Diagnostic Tests
- Total serum tryptase level
- Genetic testing (TPSAB1 gene)
- Tryptase testing
- Droplet digital PCR (ddPCR)
Treatment
Hereditary alpha-tryptasemia (HαT) is a genetic disorder characterized by elevated levels of tryptase, a mast cell mediator. While there is no cure for HαT, various drug treatments can help manage its symptoms.
Treatment Options
According to the available information, treatment options for HαT include:
- Antihistamines: These medications can help alleviate symptoms such as itching, abdominal pain, and headaches [1]. H1 antihistamines are particularly effective in managing these symptoms [2].
- Mast Cell Stabilizers: These drugs can help stabilize mast cells and reduce the release of mediators like tryptase [3].
- Leukotriene Inhibitors: These medications can also help manage symptoms by inhibiting the production of leukotrienes, which are involved in inflammation [4].
- Aspirin Therapy: Aspirin has been shown to be effective in reducing tryptase levels and alleviating symptoms in some individuals with HαT [5].
- Anti-IgE Therapy: This treatment involves targeting IgE antibodies, which play a role in mast cell activation [6].
Other Therapeutic Options
In addition to these medications, other therapeutic options may be considered on an individual basis. These include:
- PPIs (Proton Pump Inhibitors): These medications can help manage gastrointestinal symptoms associated with HαT [7].
- IgE antibodies: Targeting IgE antibodies may also be beneficial in managing symptoms [8].
It's essential to note that treatment for HαT often requires trial and error, and a lot of patience. Unfortunately, treatment may only be partially successful, but these options can help manage the symptoms.
References:
[1] Context 4 [2] Context 1 [3] Context 4 [4] Context 4 [5] Context 5 [6] Context 6 [7] Context 8 [8] Context 8
Recommended Medications
- Antihistamines
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Aspirin Therapy
- Anti-IgE Therapy
- PPIs (Proton Pump Inhibitors)
- IgE antibodies
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Hereditary alpha-tryptasemia (HαT) is a genetic trait that can be challenging to diagnose, as its symptoms may overlap with those of other conditions. A differential diagnosis approach is essential to rule out other possible causes and confirm the presence of HαT.
Conditions to consider in the differential diagnosis:
- Mast cell disorders: Conditions such as mastocytosis, systemic mastocytosis, or mast cell activation syndrome can present with similar symptoms to HαT, including anaphylaxis, skin manifestations, and gastrointestinal issues [6].
- Allergies: Patients with HαT may experience multiple allergies, which can be mistaken for other conditions such as asthma, eczema, or food intolerance [6].
- Other genetic disorders: Conditions like alpha-1 antitrypsin deficiency or cystic fibrosis may present with similar respiratory symptoms to HαT [8].
Key diagnostic features of hereditary alpha-tryptasemia:
- Elevated baseline serum tryptase (BST) levels, typically above 11.4 µg/L [5]
- Autosomal dominant inheritance pattern
- Presence of mast cell activation and mediator release symptoms, such as anaphylaxis, skin manifestations, and gastrointestinal issues [6]
Diagnostic approach:
- Thorough history-taking: A detailed medical history is essential to identify potential triggers for mast cell activation and mediator release.
- Baseline serum tryptase measurement: Measuring BST levels can help confirm the presence of HαT.
- Genetic testing: Genetic analysis may be necessary to confirm the autosomal dominant inheritance pattern and identify the TPSAB1 gene mutation associated with HαT [8].
By considering these conditions in the differential diagnosis and using a stepwise approach, healthcare providers can accurately diagnose hereditary alpha-tryptasemia syndrome.
References:
[5] Background: Hereditary alpha-tryptasemia (HAT) is a genetic predisposition of autosomal dominant inheritance that leads to a high normal (≥ 8–11.4 µg/L) or elevated baseline serum tryptase levels. [6] Most symptoms related to HαT may be explained by mast cell activation and mediator release, namely multiple allergies, anaphylaxis, and skin manifestations. [8] Genetics and Diagnosis of Hereditary Alpha-Tryptasemia. The human tryptase locus consists of 4 paralogous genes—TPSG1, TPSB2, TPSAB1, and TPST1.
Additional Differential Diagnoses
- Other genetic disorders
- Allergies
- Mast cell disorders
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3570
- owl#annotatedSource
- t357360
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080714
- core#notation
- DOID:0080714
- oboInOwl#hasDbXref
- GARD:13193
- rdf-schema#label
- hereditary alpha tryptasemia syndrome
- IAO_0000115
- A syndrome that is characterized by high blood tryptase levels and that has_material_basis_in inherited extra copies of the alpha tryptase gene (TPSAB1), effecting multiple organ systems including skin and connective tissues, the gastrointestinal and cardiovascular systems.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- rdf-schema#subClassOf
- t357507
- RO_0001000
- http://purl.obolibrary.org/obo/CL_0000097
- relatedICD
- http://example.org/icd10/D89.44
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.